Home -> Law Blog Directory -> Intellectual Property Law Blogs -> IPKat
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: IPKatUK-IPO response to performers' term extension
By Johanna Gibson, David Pearce, Jeremy Phillips and Ilanah Simon.
The UK IPO appears to have given a rather chilly reception to the European Commission?s proposal to extend performers? rights to 95 years. A press release quotes the Minister for IP, Baroness Delyth Morgan, as saying:
Because copyright represents a monopoly we need to be very clear that the circumstances justify an extension. We will therefore need to consider these proposals carefully to understand how they would work and what the benefits are likely to be?
She continues by encouraging members of public to contact the IPO with comments on the proposal by the end of August (contact details are in the press release).
The press release goes on to note that the Gowers Review found that an extension of copyright would not be beneficial to either consumers or the industry.
The IPKat agrees. 50 years of protection is hardly derisory. When we alter IP rights, we alter the competitive balance. The balancing exercise is a complex one and knee jerk or populist proposals don?t give the opportunity for this balance to be made adequately. However, the Commission seem to be rather taken with the idea of extending the term.
While the IPKat is on the subject of EU copyright, he neglected to mention last week that the Commission has adopted a decision which prohibits European collecting societies from limiting membership to authors in their particular
Full post as published by IPKat on July 22, 2008 (boomark / email).
Pesticides
Long-Term Exposure Linked to Diabetes
Long-Term Insurance Suit
Settled for $15 Million
UnumProvident
for allegedly denying long-term disability claims.

Synergy Wont Save Patent Term Extension For Combination of Known Drugs
USPTO Rejects SYMBICORT Patent Extension
Patently-O Bits and Bytes No. 53
83% Chance of Patent Term Extension Due to USPTO Delay
Term extension in Europe: just as bad an idea across the pond
Wrestling Association to Institute Concussion Management and Awarness Program









